Research interests

Dr. Marjolijn N. Lub-de Hooge

is a Hospital Pharmacist and associate professor at the department of Clinical Pharmacy and Pharmacology, and at the department of Nuclear Medicine and Molecular Imaging of the University Medical Center Groningen. She obtained her PhD on pharmaceutical aspects and molecular imaging of new receptor targeted drugs.

Her research mainly focuses on molecular imaging to support and optimize treatment of cancer patients with novel (targeted and immuno) therapies. She is an expert in the development, evaluation and translation of new radiopharmaceuticals and optical tracers to the clinical setting. And she is also involved in the subsequent clinical application of these new tracers for drug development, and treatment optimization: visualization of presence of drug target (patient selection), drug biodistribution (pharmacokinetics, optimal dosing, target saturation) and tumor status during treatment (early predictive biomarker, pharmacodynamics).



  1. Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

    Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., Oosting, S. F., Schröder, C. P., Hiltermann, T. J. N., van der Wekken, A. J., Groen, H. J. M., Kwee, T. C., Elias, S. G., Gietema, J. A., Bohorquez, S. S., de Crespigny, A., Williams, S-P., Mancao, C., Brouwers, A. H., Fine, B. M. & de Vries, E. G. E. Dec-2018 In : Nature Medicine. 24, 12, p. 1852-1858 7 p.

    Research output: Contribution to journalLetter

  2. Molecular Imaging of Radiolabeled Bispecific T-cell Engager 89Zr-AMG211 Targeting CEA-positive Tumors

    Waaijer, S. J. H., Warnders, F-J., Stienen, S. K., Friedrich, M., Sternjak, A., Cheung, H-K., Terwisscha van Scheltinga, A. G. T., Schröder, C. P., de Vries, E. G. & Lub-de Hooge, M. N. 6-Jul-2018 In : Clinical Cancer Research.

    Research output: Contribution to journalArticle

View all (92) »

View graph of relations

ID: 292049